{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:56:39Z","timestamp":1792306599177,"version":"4.4.0"},"reference-count":34,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2016,12,12]]},"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Drug interactions, poor adherence to medication and high-risk sexual behaviour may occur in individuals with HIV using recreational drugs. Thus, we aimed to assess the prevalence of recreational drugs use and to explore its clinical impact in HIV patients on treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Observational, cross sectional, study conducted in a 700 bed university hospital, Barcelona, Spain. A total of 208 adults living with HIV on treatment were included. A questionnaire was administered by clinical pharmacists, including evaluation of sociodemographic variables, past 12-month drug consumption, adherence to antiretrovirals (Simplified Medication Adherence Questionnaire) and high-risk sexual behaviour (condomless sex\/multiple partners). Additional data were obtained from clinical records. Recreational drug-antiretroviral interactions were checked in reference databases. Prevalence was calculated for 5% precision and 95% CI. Crude and adjusted binary logistic regressions were performed to identify associations between recreational drug use and adherence problems, and between recreational drug use and high-risk sexual behaviour.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From the overall sample, 92 participants (44.2%) consumed recreational drugs over the past 1\u2005year. Of these, 44 (48.8%) had used different types of recreational drugs in this period. We detected 11 recreational substances, including sildenafil and nitrites. The most consumed drugs were: cannabis (68.5%), cocaine (45.5%), nitrites (31.5%), sildenafil (28.3) and ecstasy (19.6%). Relevant interactions occurred in 46 (50%) of the individuals consuming drugs. Recreational drug consumption was found to be related to adherence problems with antiretrovirals (OR: 2.51 (95% CI 1.32 to 4.77) p=0.005) and high-risk sexual behaviour (OR: 2.81 (95% CI 1.47 to 5.39) p=0.002).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Recreational drugs are frequently used by HIV patients on treatment. Classical drugs and new substances consumed in sexual context are usual. Recreational drug consumption interferes with several clinical outcomes, including potentially relevant interactions between drugs and antiretrovirals, adherence problems and high-risk sexual behaviour. Thus, there is the urgent need of implementing patient-centred care involving recreational drug consumption.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2016-014105","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T20:41:35Z","timestamp":1484772095000},"page":"e014105","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":35,"title":["Prevalence and clinical impact of recreational drug consumption in people living with HIV on treatment: a cross-sectional study"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1559-9453","authenticated-orcid":false,"given":"Noe","family":"Garin","sequence":"first","affiliation":[{"name":"Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Instituto de Salud Carlos III, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental (CIBERSAM), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Zurita","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Velasco","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Epidemiology, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain"},{"name":"ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Cl\u00ednic, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Feliu","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Gutierrez","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Hospital de la Santa Creu i Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Masip","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Antonia","family":"Mangues","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Instituto de Salud Carlos III, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Bioingenier\u00eda, Biomateriales y Nanomedicina (CIBER-BBN), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,1,18]]},"reference":[{"key":"2025121220152972000_7.1.e014105.1","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). Fact sheet 2015. Global statistics, 2015. http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/20150901_FactSheet_2015_en.pdf"},{"key":"2025121220152972000_7.1.e014105.2","unstructured":"Secretar\u00eda General de Sanidad, Direcci\u00f3n General de Salud P\u00fablica, Calidad e Innovaci\u00f3n. Informe nacional sobre los progresos realizados en la aplicaci\u00f3n del GARPR, Espa\u00f1a. Enero 2015\u2014diciembre 2015. Ministerio de Sanidad, Servicio Sociales e Igualdad, Espa\u00f1a. 2016. http:\/\/www.unaids.org\/sites\/default\/files\/country\/documents\/ESP_narrative_report_2016.pdf"},{"key":"2025121220152972000_7.1.e014105.3","unstructured":"Direcci\u00f3n General de Salud P\u00fablica, Calidad e Innovaci\u00f3n. Vigilancia Epidemol\u00f3gica del VIH y SIDA en Espa\u00f1a, actualizaci\u00f3n 30 de junio de 2015. Ministerio de Sanidad, Servicios Sociales e Igualdad, Espa\u00f1a. 2015. http:\/\/www.msssi.gob.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/sida\/vigilancia\/InformeVIH_SIDA_2015.pdf"},{"key":"2025121220152972000_7.1.e014105.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61809-7"},{"key":"2025121220152972000_7.1.e014105.5","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. European Drug Report. Trends and Developments. 2015. http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/974\/TDAT15001ENN.pdf"},{"key":"2025121220152972000_7.1.e014105.6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.drugalcdep.2014.05.005","article-title":"Prevalence and patterns of smoking, alcohol use, and illicit drug use in young men who have sex with men","volume":"141","author":"Newcomb","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"2025121220152972000_7.1.e014105.7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10550880903014726","article-title":"Comparison of substance use and risky sexual behavior among a diverse sample of urban, HIV-positive men who have sex with men","volume":"28","author":"Hatfield","year":"2009","journal-title":"J Addict Dis"},{"key":"2025121220152972000_7.1.e014105.8","unstructured":"The EMIS Network. EMIS 2010: the European men-who-have-sex-with-men internet survey. Findings from 38 countries. Stockholm: European Centre for Disease Prevention and Control, 2013."},{"key":"2025121220152972000_7.1.e014105.9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.medcli.2014.04.030","article-title":"[High prevalence of drug consumption and sexual risk behaviors in men who have sex with men]","volume":"145","author":"Folch","year":"2015","journal-title":"Med Clin (Barc)"},{"key":"2025121220152972000_7.1.e014105.10","unstructured":"World Health Organization. WHO|Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. WHO Press World Heal Organ Geneva, Switzerland. World Health Organization, 2014. http:\/\/www.who.int\/hiv\/pub\/guidelines\/keypopulations\/en\/"},{"key":"2025121220152972000_7.1.e014105.11","first-page":"690","article-title":"Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations","volume":"6","author":"Garin","year":"2015","journal-title":"Front Microbiol"},{"key":"2025121220152972000_7.1.e014105.12","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(14)70001-3"},{"key":"2025121220152972000_7.1.e014105.13","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2007.0122"},{"key":"2025121220152972000_7.1.e014105.14","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000786"},{"key":"2025121220152972000_7.1.e014105.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2010.09.012"},{"key":"2025121220152972000_7.1.e014105.16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/QAI.0000000000000776","article-title":"Intentional medication nonadherence because of interactive toxicity beliefs among HIV-positive active drug users","volume":"70","author":"Kalichman","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025121220152972000_7.1.e014105.17","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2015-052052"},{"key":"2025121220152972000_7.1.e014105.18","doi-asserted-by":"publisher","DOI":"10.1080\/00224499.2011.558645"},{"key":"2025121220152972000_7.1.e014105.19","doi-asserted-by":"crossref","first-page":"e0126320","DOI":"10.1371\/journal.pone.0126320","article-title":"Club drugs and HIV\/STD infection: an exploratory analysis among men who have sex with men in Changsha, China","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS ONE"},{"key":"2025121220152972000_7.1.e014105.20","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.2014.75.153"},{"key":"2025121220152972000_7.1.e014105.21","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200203080-00012"},{"key":"2025121220152972000_7.1.e014105.22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1521\/aeap.1998.10.4.293","article-title":"Measuring condom use: asking \u201cdo you or don't you\u201d isn't enough","volume":"10","author":"Weir","year":"1998","journal-title":"AIDS Educ Prev"},{"key":"2025121220152972000_7.1.e014105.23","doi-asserted-by":"publisher","DOI":"10.1136\/jech.53.7.417"},{"key":"2025121220152972000_7.1.e014105.24","unstructured":"Liverpool HIV Pharmacology Group (LHPG). HIV drug interactions webpage. http:\/\/www.hiv-druginteractions.org\/"},{"key":"2025121220152972000_7.1.e014105.25","first-page":"267","article-title":"[Estimation of the sample size in clinical and epidemiological investigations]","volume":"111","author":"Marrugat","year":"1998","journal-title":"Med Clin (Barc)"},{"key":"2025121220152972000_7.1.e014105.26","unstructured":"European Monitoring Center for Drugs and Drug Addiction. 2015. http:\/\/www.emcdda.europa.eu\/"},{"key":"2025121220152972000_7.1.e014105.27","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2013-051195"},{"key":"2025121220152972000_7.1.e014105.28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017781"},{"key":"2025121220152972000_7.1.e014105.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2006.05.047"},{"key":"2025121220152972000_7.1.e014105.30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1586\/17512433.1.1.115","article-title":"Pharmacokinetic drug interactions between drugs of abuse and antiretroviral medications: implications and management for clinical practice","volume":"1","author":"Bruce","year":"2008","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2025121220152972000_7.1.e014105.31","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/QAD.0000000000000994","article-title":"Prevalence of recreational drug use is indiscriminate across antiretroviral regimens of differing drug-drug interactions among MSM","volume":"30","author":"Daskalopoulou","year":"2016","journal-title":"AIDS"},{"key":"2025121220152972000_7.1.e014105.32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10461-014-0927-4","article-title":"Level of adherence and HIV RNA suppression in the current era of Highly Active Antiretroviral Therapy (HAART)","volume":"19","author":"Viswanathan","year":"2014","journal-title":"AIDS Behav"},{"key":"2025121220152972000_7.1.e014105.33","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1468-1293.2012.01005.x","article-title":"Substance use and sexual risk behaviour among HIV-positive men who have sex with men in specialized out-patient clinics","volume":"13","author":"Dirks","year":"2012","journal-title":"HIV Med"},{"key":"2025121220152972000_7.1.e014105.34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.5148"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2016-014105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T04:15:39Z","timestamp":1765599339000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2016-014105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,18]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1136\/bmjopen-2016-014105"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2016-014105","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}